Evidence map›Paper›PMID 27296562›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2016

Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis.

Joseph M Collaco, Karen S Raraigh, Lawrence J Appel, Garry R Cutting

Registry-linked trialOpen access · bronzeAbstract readTwin Study
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00037765 (Gene Modifiers of Cystic Fibrosis Lung Disease), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00037765 active not recruitingnot on this map

Gene Modifiers of Cystic Fibrosis Lung Disease

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2001 to 2027Enrolled600ConditionsCystic Fibrosis, Lung Diseases
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joseph M CollacoThe Johns Hopkins Medical Institutions, Baltimore, MD, United States.
Karen S RaraighThe Johns Hopkins Medical Institutions, Baltimore, MD, United States.
Lawrence J AppelThe Johns Hopkins Medical Institutions, Baltimore, MD, United States.
Garry R CuttingThe Johns Hopkins Medical Institutions, Baltimore, MD, United States.
Johns Hopkins University · US

Funding

Genetic Modifiers of Cystic Fibrosis: Sibling StudyR01HL068927 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CUTTING, GARRY R · 2001 to 2011
$8.9M
Gene-Environment Interactions in Cystic Fibrosis Lung DiseaseR01HL128475 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI COLLACO, JOSEPH MICHAEL · 2016 to 2019
$1.1M
NHLBI NIH HHS R01 HL068927NHLBI NIH HHS R01 HL128475
6 · The paper itself

Abstract

introductionMean annual ambient temperature is a replicated environmental modifier of cystic fibrosis (CF) lung disease with warmer temperatures being associated with lower lung function. The mechanism of this relationship is not completely understood. However, Pseudomonas aeruginosa, a pathogen that infects the lungs of CF individuals and decreases lung function, also has a higher prevalence in individuals living in warmer climates. We therefore investigated the extent to which respiratory pathogens mediated the association between temperature and lung function.

methodsThirteen respiratory pathogens observed on CF respiratory cultures were assessed in multistep fashion using clustered linear and logistic regression to determine if any mediated the association between temperature and lung function. Analysis was performed in the CF Twin-Sibling Study (n=1730; primary population); key findings were then evaluated in the U.S. CF Foundation Data Registry (n=15,174; replication population).

resultsIn the primary population, three respiratory pathogens (P. aeruginosa, mucoid P. aeruginosa, and methicillin-resistant Staphylococcus aureus) mediated the association between temperature and lung function. P. aeruginosa accounted for 19% of the association (p=0.003), mucoid P. aeruginosa for 31% (p=0.001), and MRSA for 13% (p=0.023). The same three pathogens mediated association in the replication population (7%, p<0.001; 7%, p=0.002; and 4%, (p=0.002), respectively).

conclusionsThree important respiratory pathogens in CF mediate the association between lower lung function and warmer temperatures. These findings have implications for understanding regional variations in clinical outcomes, and interpreting results of epidemiologic studies and clinical trials that encompass regions with different ambient temperatures.

Indexed as

Cystic FibrosisEnvironmental ExposurePseudomonas InfectionsRespiratory Tract InfectionsStaphylococcal InfectionsTemperatureAdultChildFemaleHumansLungMaleMethicillin-Resistant Staphylococcus aureusPrevalencePseudomonas aeruginosaRespiratory Function TestsClimateCystic fibrosisFEV1Lung functionMRSAPseudomonas aeruginosaTemperature

Identifiers

PMID27296562
PMCPMC5138086
OpenAlexW2409140075

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.